EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined In Silico and In Vitro Analyses to Assess the Anticancer Potential of Thiazolidinedione–Thiosemicarbazone Hybrid Molecules

Agata Paneth iD, Barbara Kaproń iD, Tomasz Plech iD, Roman Paduch iD, Nazar Trotsko iD, Piotr Paneth iD

International Journal of Molecular Sciences · 15.12.2023 · 24 (24) · 17521

DOI: 10.3390/ijms242417521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.12.2023. Verfasst von Agata Paneth und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, 20-059 Lublin, Poland. Hauptthemen laut MEDLINE: Thiosemicarbazones, Antineoplastic Agents, Thiazolidinediones. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The number of people affected by cancer and antibiotic-resistant bacterial infections has increased, such that both diseases are already seen as current and future leading causes of death globally. To address this issue, based on a combined in silico and in vitro approach, we explored the anticancer potential of known antibacterials with a thiazolidinedione–thiosemicarbazone (TZD–TSC) core structure. A cytotoxicity assessment showed encouraging results for compounds 2–4, with IC50 values against T98G and HepG2 cells in the low micromolar range. TZD–TSC 3 proved to be most toxic to cancer cell lines, with IC50 values of 2.97 ± 0.39 µM against human hepatoma HepG2 cells and IC50 values of 28.34 ± 2.21 µM against human glioblastoma T98G cells. Additionally, compound 3 induced apoptosis and showed no specific hemolytic activity. Furthermore, treatment using 3 on cancer cell lines alters these cells’ morphology and further suppresses migratory activity. Molecular docking, in turn, suggests that 3 would have the capacity to simultaneously target HDACs and PPARγ, by the activation of PPARγ and the inhibition of both HDAC4 and HDAC8. Thus, the promising preliminary results obtained with TZD–TSC 3 represent an encouraging starting point for the rational design of novel chemotherapeutics with dual antibacterial and anticancer activities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiosemicarbazonesAntineoplastic AgentsThiazolidinedionesHumansStructure-Activity RelationshipCell Line, TumorMolecular Docking SimulationPPAR gammaDrug Screening Assays, AntitumorAnti-Bacterial AgentsMolecular StructureCell ProliferationHistone DeacetylasesRepressor Proteins

Stichwörter der Autor:innen

HDACsPPARγapoptosiscell migrationcytotoxic effecthemolytic activitymolecular dockingthiazolidinedionethiosemicarbazone

Substanzen

ThiosemicarbazonesPPAR gammaAntineoplastic Agents2,4-thiazolidinedioneThiazolidinedionesAnti-Bacterial AgentsHDAC8 protein, humanHistone DeacetylasesRepressor Proteins

Autor:innen und Institutionen

  • Chair and Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, 20-059 Lublin, Poland.
  • Department of Clinical Genetics, Faculty of Medicine, Medical University of Lublin, 20-080 Lublin, Poland.
  • Department of Pharmacology, Faculty of Health Sciences, Medical University of Lublin, 20-080 Lublin, Poland.
  • Department of Virology and Immunology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, 20-033 Lublin, Poland.
  • Institute of Applied Radiation Chemistry, Faculty of Chemistry, Lodz University of Technology, 90-924 Lodz, Poland.

ORCID-Profile: Agata Paneth, Barbara Kaproń, Tomasz Plech, Roman Paduch, Nazar Trotsko, Piotr Paneth

Förderung

  • Medical University of Lublin, Poland

Zitieren

APA

Paneth, A., Kaproń, B., Plech, T., Paduch, R., Trotsko, N., & Paneth, P. (2023). Combined In Silico and In Vitro Analyses to Assess the Anticancer Potential of Thiazolidinedione–Thiosemicarbazone Hybrid Molecules. International Journal of Molecular Sciences, 24(24), 17521. https://doi.org/10.3390/ijms242417521

Vancouver

Paneth A, Kaproń B, Plech T, Paduch R, Trotsko N, Paneth P. Combined In Silico and In Vitro Analyses to Assess the Anticancer Potential of Thiazolidinedione–Thiosemicarbazone Hybrid Molecules. International Journal of Molecular Sciences. 2023;24(24):17521. doi:10.3390/ijms242417521

BibTeX
@article{Paneth2023,
  author = {Paneth, Agata and Kaproń, Barbara and Plech, Tomasz and Paduch, Roman and Trotsko, Nazar and Paneth, Piotr},
  title = {Combined In Silico and In Vitro Analyses to Assess the Anticancer Potential of Thiazolidinedione–Thiosemicarbazone Hybrid Molecules},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {24},
  pages = {17521},
  doi = {10.3390/ijms242417521}
}
Kostenlos starten →